Your browser doesn't support javascript.
loading
An audience with...Joseph Bolen. Interview by Bethan Hughes.
Nat Rev Drug Discov ; 8(8): 608, 2009 Aug.
Article em En | MEDLINE | ID: mdl-19644470
Chief Scientific Officer, Millennium: The Takeda Oncology Company,Cambridge, Massachusetts, USA. Prior to joining Millennium, Joseph Bolen, Ph.d., held positions including Vice President and Global head of Oncologic diseases at hoechst Marion Roussel, and executive director of oncology drug discovery at the Bristol-Myers Squibb Pharmaceutical Research institute. in addition to other senior academic positions, he was Section Chief of the Biochemical Oncology Department at the National Cancer Institute in Maryland, USA, and a founding member of their laboratory of tumor virus biology.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Indústria Farmacêutica / Antineoplásicos Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Indústria Farmacêutica / Antineoplásicos Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2009 Tipo de documento: Article